Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Dale

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|June 3, 2008
Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropeniaAlister C Ward, Judith Gits, Fidel Majeed, et al.
Transfusion|November 8, 2002
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donorsKai Hübel, Rachel A Carter, W Conrad Liles, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Supportive Cancer Therapy|July 17, 2008
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 AntagonistKai Hübel, W Conrad Liles, Hal E Broxmeyer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2022
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choicesRobert M Rifkin, Jeffrey Crawford, Reshma L Mahtani, et al.
Gynecologic Oncology|December 25, 2012
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancerRabbie K Hanna, Marek S Poniewierski, Robin A Laskey, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2022
Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropeniaPeter Sabo, Vahagn Makaryan, Yosef Dicken, et al.
British Journal of Haematology|May 12, 2010
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapyPhilip S Rosenberg, Cornelia Zeidler, Audrey A Bolyard, et al.
Blood|February 25, 2006
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapyPhilip S Rosenberg, Blanche P Alter, Audrey A Bolyard, et al.
British Journal of Haematology|November 22, 2007
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropeniaPhilip S Rosenberg, Blanche P Alter, Daniel C Link, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|June 3, 2008
Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropeniaAlister C Ward, Judith Gits, Fidel Majeed, et al.
Transfusion|November 8, 2002
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donorsKai Hübel, Rachel A Carter, W Conrad Liles, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Supportive Cancer Therapy|July 17, 2008
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 AntagonistKai Hübel, W Conrad Liles, Hal E Broxmeyer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2022
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choicesRobert M Rifkin, Jeffrey Crawford, Reshma L Mahtani, et al.
Gynecologic Oncology|December 25, 2012
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancerRabbie K Hanna, Marek S Poniewierski, Robin A Laskey, et al.
Molecular Therapy. Methods & Clinical Development|July 7, 2022
Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropeniaPeter Sabo, Vahagn Makaryan, Yosef Dicken, et al.
British Journal of Haematology|May 12, 2010
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapyPhilip S Rosenberg, Cornelia Zeidler, Audrey A Bolyard, et al.
Blood|February 25, 2006
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapyPhilip S Rosenberg, Blanche P Alter, Audrey A Bolyard, et al.
British Journal of Haematology|November 22, 2007
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropeniaPhilip S Rosenberg, Blanche P Alter, Daniel C Link, et al.
Pageof 15